Clinical trial
HYPERtension Reduction Through WALKing Stairs Versus Brisk Walking in Individuals With Increased Cardiometabolic Risk - The HYPERWALK Randomized Controlled Trial
NCT06952348 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- HYPERtension Reduction Through WALKing Stairs Versus Brisk Walking in Individuals With Increased Cardiometabolic Risk - The HYPERWALK Randomized Controlled Trial
- Lead sponsor
- Karolinska Institutet
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- November 27, 2025
- Completion date
- May 31, 2029
- Enrollment
- 450 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
cardiovascular diseases, hypertension, metabolic disease, obesity and overweight